Showing results (561-570 of 2,688) with videos related to
Sort By:
Pageof 269
The Lancet. Infectious Diseases|August 13, 2021
Effects of antibiotic resistance, drug target attainment, bacterial pathogenicity and virulence, and antibiotic access and affordability on outcomes in neonatal sepsis: an international microbiology and drug evaluation prospective substudy (BARNARDS)Kathryn M Thomson, Calie Dyer, Feiyan Liu, et al.The Lancet. Infectious Diseases|July 19, 2025
Human papillomavirus (HPV) type 16 and type 18 antibody concentrations after a single dose of bivalent HPV vaccine in girls aged 9-14 years compared with three doses of quadrivalent HPV vaccine in women aged 18-25 years in Costa Rica (PRIMAVERA): a non-randomised, open-label, immunobridging, non-inferiority trialBernal Cortés, Rebeca Ocampo, Carolina Porras, et al.The Lancet. Infectious Diseases|July 12, 2025
Invasive group A streptococcal infections: lessons learned from the 2022-23 upsurgeAlix Flamant, Alicia Demirjian, Theresa Lamagni, et al.The Lancet. Infectious Diseases|December 13, 2025
Lessons derived from a 3-year congenital cytomegalovirus screening programme in Israel: a prospective population-based cohort studySmadar Eventov Friedman, Noa Ofek Shlomai, Esther Oiknine-Djian, et al.The Lancet. Infectious Diseases|December 11, 2025
Transitioning to people-centred antimicrobial resistance surveillanceDirek Limmathurotsakul, Raheelah Ahmad, Elizabeth A Ashley, et al.The Lancet. Infectious Diseases|November 30, 2025
The epidemiology of chikungunya virus in Brazil and the potential impact of vaccines: a mathematical modelling studyOscar Cortes-Azuero, Megan O'Driscoll, Gabriel Ribeiro Dos Santos, et al.The Lancet. Infectious Diseases|December 20, 2024
Sustainable antimicrobial resistance surveillance: time for a global funding mechanismChris Painter, Direk Limmathurotsakul, Tamalee Roberts, et al.The Lancet. Infectious Diseases|December 15, 2024
Ebola disease: bridging scientific discoveries and clinical applicationAmanda Rojek, Joshua Fieggen, Paska Apiyo, et al.The Lancet. Infectious Diseases|December 20, 2024
Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysisMaria Garcia Quesada, Meagan E Peterson, Julia C Bennett, et al.Pageof 269